Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6256736 | 0.99 | CYP2D6 (0.55) | CYP2D6KDM4EPOLBKMT2AALDH1A1 | |
| SCHEMBL6256508 | 0.89 | KMT2A (0.44) | CYP2D6KDM4EPOLBKMT2AALDH1A1 | |
| SCHEMBL6259368 | 0.88 | SLC18A2 (0.43) | CYP2D6KDM4EPOLBKMT2AALDH1A1 | |
| SCHEMBL6188797 | 0.74 | CYP2D6 (0.55) | CYP2D6KDM4EPOLBKMT2AALDH1A1 | |
| SCHEMBL7705235 | 0.73 | CYP2D6 (0.54) | CYP2D6KMT2ALMNAMAPK1HTT | |
| SCHEMBL4500156 | 0.73 | EPHX2 (0.59) | CYP2D6KDM4EPOLBALDH1A1TSHR | |
| SCHEMBL4503243 | 0.72 | EPHX2 (0.57) | CYP2D6KDM4EKMT2ALMNADRD4 | |
| SCHEMBL5226751 | 0.71 | CYP2D6 (0.54) | CYP2D6LMNAMAPK1HTT | |
| SCHEMBL8734239 | 0.70 | SLC18A3 (0.72) | CYP2D6ALDH1A1LMNADRD4 | |
| SCHEMBL6256607 | 0.68 | CYP2D6 (0.47) | CYP2D6KMT2ALMNAMAPK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1806346-A1 | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | CV THERAPEUTICS, INC. (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1578737-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | CV THERAPEUTICS, INC. (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1567525-A2 | SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS | CV THERAPEUTICS, INC. (US) | 2005-08-31 | — | — | EP | disclosed |
| WO-2004063180-A1 | SUBSTITUTED HETEROCYCLIC COMPOUNDS | CV THERAPEUTICS, INC. (US) | 2004-07-29 | — | — | WO | disclosed |
| WO-2004052887-A2 | SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS | CV THERAPEUTICS, INC. (US) | 2004-06-24 | — | — | WO | disclosed |